Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of F-1311 in Patients with Prostate Cancer
jRCT2080222723Phase 2Completed
- Sponsor
- PDRadiopharma Inc.
- Start
- Jan 2015
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trofolastat in prostate cancer (PCa), sponsored by PDRadiopharma Inc. Started Jan 2015; status: completed.
02
Drugs
trofolastat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT2080222723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222723.